14417-88-0 Usage
Uses
Used in Pharmaceutical Industry:
Melinamide is used as a therapeutic agent for the treatment of hypercholesterolemia. Its ability to inhibit cholesterol absorption from the gastrointestinal tract makes it a valuable addition to the arsenal of drugs used to manage cholesterol levels and prevent cardiovascular diseases.
Used in Anti-inflammatory Applications:
Melinamide is utilized in the synthesis and biological screening of a library of macamides, which are known to act as TNF alpha inhibitors. These inhibitors possess greater anti-inflammatory activity in human monocytic cells, making melinamide a crucial component in the development of novel anti-inflammatory drugs.
Brand Name:
Melinamide is commercially available under the brand name ARTES OIL, which is specifically formulated to harness the cholesterol-lowering and anti-inflammatory properties of melinamide for the benefit of patients suffering from hypercholesterolemia and inflammation-related conditions.
Originator
Sumitomo (Japan)
Hazard
Low toxicity by ingestion.
Check Digit Verification of cas no
The CAS Registry Mumber 14417-88-0 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,4,4,1 and 7 respectively; the second part has 2 digits, 8 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 14417-88:
(7*1)+(6*4)+(5*4)+(4*1)+(3*7)+(2*8)+(1*8)=100
100 % 10 = 0
So 14417-88-0 is a valid CAS Registry Number.
InChI:InChI=1/C26H41NO/c1-3-4-5-6-7-8-9-10-11-12-13-14-15-16-20-23-26(28)27-24(2)25-21-18-17-19-22-25/h7-8,10-11,17-19,21-22,24H,3-6,9,12-16,20,23H2,1-2H3,(H,27,28)/b8-7+,11-10+
14417-88-0Relevant articles and documents
Synthesis and biological screening of a library of macamides as TNF-α inhibitors
Apaza Ticona, Luis,Serban, Andreea Madalina,Acero Gómez, Javier,Rumbero Sánchez, ángel,Tena Pérez, Víctor
, p. 1196 - 1209 (2020/11/03)
Thirty-five macamide analogues were synthesised by modifying the initial molecular structure. The resulting structures were confirmed using NMR and MS. Cytotoxicity and the anti-inflammatory activity of these synthetic macamides were evaluated in the THP-1 cell line. Preliminary biological evaluation indicated that most of these synthetic macamides did not present cytotoxicity (MTT assay) in the tested cell line with respect to the control (actinomycin D). Regarding the anti-inflammatory activity, several analogues had a greater potential for inhibition of TNF-α than natural macamides. Synthetic macamide 4a was the most active (IC50 = 0.009 ± 0.001 μM) compared to the C87 (control). Through looking at the link between the chemical structure and the activity, our study proves that changes made to natural macamides at the level of the alkyl chain, the benzyl position, the amide bond, and the addition of two methyl groups to the aromatic ring (meta position) lead us to obtaining new macamides with greater anti-inflammatory activity. This journal is